related documents
- A Randomized trial of long term dalteparin low molecular weight heparin (LMWH) versus oral anticoagulant (OA) therapy in cancer patients with venous thromboembolism (VTE). Conferences
- A prospective study of clinical laboratory findings in patients referred by a hematologist for investigation of a suspected platelet disorder. Conferences
- A randomized double-blind placebo-controlled study of low dose warfarin for the prevention of symptomatic central venous catheter-associated thrombosis in patients with cancer. Conferences
- A randomized phase I clinical and biologic study of two schedules of the raf-kinase inhibitor BAY 43-9006 in patients with myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML): A NCI Canada clinical trials group study Conferences
- A randomized trial of two intensities of warfarin (international normalized ratio of 2.0 to 3.0 versus 3.1 to 4.0) for the prevention of recurrent thrombosis in patients with antiphospholipid antibodies. Conferences
- An assessment of APTT heparin therapeutic reference intervals in Ontario Conferences
- Analysis of fetal DNA present in maternal plasma, for the prenatal diagnostic work-up of fetuses at risk of inheriting beta-thalassemia major. Conferences
- Bleeding complications of thromboprophylaxis after hip replacement: A systematic review. Conferences
- Cardiobacterium hominis endocarditis masquerading as very severe refractory immune thrombocytopenic purpura: Report of a case. Conferences
- Case-fatality for major bleeding and intracranial hemorrhage in patients with venous thromboembolism on long-term oral anticoagulant therapy: A systematic review. Conferences
- Combination therapy with rituximab and fludarabine is highly active in Waldenstrom's macroglobulinemia. Conferences
- Comparison of activated clotting time values between Hemochron signature and Hemochron 801. Conferences
- Control of plasma thrombin generation on fetal distal lung epithelium by covalent serpin-heparinoid complexes. Conferences
- Diagnosis of deep vein thrombosis during pregnancy: A pilot study evaluating the role of D-dimer and compression leg ultrasound during pregnancy. Conferences
- Dissociation of vWF-cleaving protease activity and platelet count in a patient with familial thrombotic thrombocytopenia purpura. Conferences
- Effect of age on the benefit-risk ratio of fondaparinux thromboprophylaxis in patients undergoing major orthopedic surgery. Conferences
- Effects of a novel venous-return assist device ("venowave") on lower limb venous flow in patients with post-thrombotic syndrome Conferences
- Efficacy of aspirin treatment in pediatric stroke patients as measured with the PFA-100. Conferences
- Elevated levels of D-dimer upon central venous catheter introduction identify patients at high risk of developing subclavian vein thrombosis. Conferences
- Evaluation of a directed donor transfusion program in the Neonatal Intensive Care Unit: Does directed donation reduce allogeneic exposures to neonates? Conferences
- Evidence of intracellular activation of the fibrinolytic cascade in the Quebec Platelet Disorder. Conferences
- Experiences of continuous infusion of B-domain deleted recombinant factor VIII (ReFacto (R)) for major surgery. Conferences
- Extended secondary prevention with the oral direct thrombin inhibitor ximelagatran for 18 months after 6 months of anticoagulation in patients with venous thromboembolism:: A randomized, placebo-controlled trial. Conferences
- Extended thromboprophylaxis in acutely ill medical patients with prolonged immobilisation: The EXCLAIM study. Conferences
- GH9001, a novel antithrombotic agent, is more effective than low-molecular-weight heparin or hirudin in rabbit models. Conferences
- Gemcitabine, dexamethasone, cisplatin (GDP) salvage chemotherapy for relapsed or refractory Hodgkin's disease (HD): A National Cancer Institute of Canada Clinical Trials Group Study. Conferences
- Gemcitabine, dexamethasone, cisplatin for relapsed or refractory non-Hodgkin's lymphoma (NHL): A National Cancer Institute of Canada Clinical Trials Group study. Conferences
- Gender and risk of immune heparin-induced thrombocytopenia (HIT). Conferences
- Genetic polymorphisms in the noncoding sequences of the PF4 and PF4alt genes are not associated with the development of heparin-induced thrombocytopenia. Conferences
- Heparin catalysis of factor IXa inhibition by antithrombin depends on both pentasaccharide-induced conformational changes in antithrombin and heparin-mediated bridging of antithrombin to factor IXa. Conferences
- Immunization to platelet alloantigens: A ten-year retrospective study. Conferences
- Influence of the duration of fondaparinux prophylaxis in preventing venous thromboembolism following hip fracture surgery. Conferences
- Inherited factor VII deficiency and thrombosis in relation to FVII genotype and thrombophilia. Conferences
- Interobserver agreement on ultrasound measurements of thrombus diameter and length: Derivation of criteria for the diagnosis of recurrent deep vein thrombosis. Conferences
- Kinetics of platelet activation, P-selectin expression and leukocyte rolling during arterial thrombus formation in vivo. Conferences
- Low molecular weight heparin (LMWH) therapy and survival in advanced cancer. Conferences
- Low-intensity (INR 1.5-1.9) versus conventional-intensity (INR 2.0-3.0) anticoagulation for extended treatment of unprovoked VTE: A randomized double blind trial. Conferences
- Natural history of arterial and venous thrombosis in children treated with low molecular weight heparin: A longitudinal study by Doppler ultrasound. Conferences
- Prophylactic growth factor use in older patients with previously untreated acute myeloid leukemia: A published data meta-analysis. Conferences
- Prospective Multicentre trial of bridging therapy with dalteparin for patients who require temporary discontinuation of OAC for prosthetic valves or high risk atrial fibrillation. Conferences
- Quality of life assessment for oncology patients: Assessing the clinical significance. Conferences
- Recombinant activated factor VII for massive hemorrhage in non-hemophilia patients: The Australian experience. Conferences
- Reduction of out-of-hospital symptomatic venous thromboembolism by extended thromboprophylaxis with low molecular weight heparin following elective hip arthroplasty. A systematic review. Conferences
- Severe bleeding problems in patients with acquired delta-storage pool disorder (delta-SPD) due to myelodysplastic and myeloproliferative disorders. Conferences
- Successful dose adjusted replacement therapy in acquired factor XIII deficiency. Conferences
- The Influence of age on in vitro plasmin generation in the presence of fibrin monomer Conferences
- The mTOR inhibitors rapamycin and RAD001 are active in experimental models of ALL and are antagonized by interleukin-7. Conferences
- Ultrasound measurement of thrombus cross-sectional area instead of thrombus diameter: A better way to diagnose recurrent deep vein thrombosis. Conferences
- Variation of APTT EQA results obtained with various combinations of coagulation instruments and APTT reagents Conferences
- Venous thromboembolism risk assessment in medical patients. Conferences